You are here

The Influence of Thyroid Hormones on Leptin and Resistin Levels in Hyperthyroid Female Patients

Journal Name:

Publication Year:

Author Name
Abstract (2. Language): 
Background: Hyperthyroidism or thyrotoxicosis occurs due to excess release of thyroid hormone. These hormones regulate the body’s energy balance and have effects on adipokine level. There are several reports suggesting interrelation between adipokines (resistin and leptin) with thyroid dysfunction. Objectives: This study was established to investigate the effect of thyroid hormones in hyperthyroidism state on the level of some adipokines, leptin and resistin; in comparison with control. Patients and Methods: The present study included 50 Iraqi female patients with hyperthyroidism with age ranged between 30-58 years and 30 healthy controls with age ranged between 30-53 years. Serum samples were collected from study groups. The levels of thyroid hormones (TSH, T4 and T3) were determined by using automated Chemiluminescence Immunoassay (CLIA) analysis system. Detection of leptin hormone and resistin hormone levels in the serum were determined by an enzyme linked immunosorbent assay (ELISA) kits. Results: The results revealed that serum leptin levels were significantly low (P<0.004) in hyperthyroid patient groups as compared to control, and there were significant negative correlations between T4 and leptin (P<0.0001); also, T3 and leptin (P<0.05). Resistin hormone level increased non-significantly (P˃0.05) than control level; and there was significant negative correlation between TSH and resistin (P<0.035). Conclusion: The study shows that there is complex interrelation between adipocytokines (leptin and resistin) with thyroid gland and pituitary gland. Leptin levels were decreased in hyperthyroid patients than control and associated negatively with T4 and T3 levels, while resistin levels were increased non-significantly than control and associated negatively with TSH level. They affect each other in their physiological function in the human body.
40
47

REFERENCES

References: 

[1] Reddy, Vivek, et al. “Atrial fibrillation and hyperthyroidism: A literature review.” Indian Heart Journal, Vol. 69,
No. 4, 2017, pp. 545-50.
[2] Ross, Douglas S., et al. “2016 American thyroid association guidelines for diagnosis and management of
hyperthyroidism and other causes of thyrotoxicosis.” Thyroid, Vol. 26, No. 10, 2016, pp. 1343-1421.
[3] Cinar, Nese, and Alper Gurlek. “Association between novel adipocytokines adiponectin, vaspin, visfatin, and
thyroid: An experimental and clinical update.” Endocrine Connections, Vol. 2, No. 4, 2013, pp. R30-R38.
[4] Aydogan, Berna İmge, and Mustafa Sahin. “Adipocytokines in thyroid dysfunction.” ISRN Inflammation, Vol.
2013, 2013.
[5] Knudsen, Nils, et al. “Small differences in thyroid function may be important for body mass index and the
occurrence of obesity in the population.” The Journal of Clinical Endocrinology & Metabolism, Vol. 90, No. 7,
2005, pp. 4019-24.
[6] Hotamisligil, Gökhan S. “Inflammation and metabolic disorders.” Nature 444.7121 (2006): 860-867.
Al-Hindawi Sahar H Int J Med Res Health Sci 2018, 7(1): 40-47
46
[7] Ouchi, Noriyuki, et al. “Adipokines in inflammation and metabolic disease.” Nature Reviews Immunology, Vol.
11, No. 2, 2011, pp. 85-97.
[8] Azamar-Llamas, Daniel, et al. “Adipokine contribution to the pathogenesis of osteoarthritis.” Mediators of
Inflammation, Vol. 2017, 2017.
[9] Parimisetty, Avinash, et al. “Secret talk between adipose tissue and central nervous system via secreted factors-an
emerging frontier in the neurodegenerative research.” Journal of Neuroinflammation, Vol. 13, No. 1, 2016, p. 67.
[10] Pathak, Nitya N., et al. “Anti-inflammatory and chondroprotective effects of atorvastatin in a cartilage explant
model of osteoarthritis.” Inflammation Research, Vol. 64, No. 3-4, 2015, pp. 161-69.
[11] Neumann, Elena, et al. “Adipokines in bone disease.” Nature Reviews Rheumatology, Vol. 12, No. 5, 2016, pp.
296-302.
[12] Vuolteenaho, Katriina, et al. “Leptin enhances synthesis of proinflammatory mediators in human osteoarthritic
cartilage-mediator role of NO in leptin-induced, IL-6, and IL-8 production.” Mediators of Inflammation, Vol.
2009, 2009.
[13] Chilliard, Y., C. Delavaud, and M. Bonnet. “Leptin expression in ruminants: nutritional and physiological
regulations in relation with energy metabolism.” Domestic Animal Endocrinology, Vol. 29, No. 1, 2005, pp. 3-22.
[14] Menendez, C., et al. “TSH stimulates leptin secretion by a direct effect on adipocytes.” Journal of
Endocrinology, Vol. 176, No. 1, 2003, pp. 7-12.
[15] Rajala, Michael W., et al. “Regulation of resistin expression and circulating levels in obesity, diabetes, and
fasting.” Diabetes, Vol. 53, No. 7, 2004, pp. 1671-79.
[16] Steppan, Claire M., et al. “The hormone resistin links obesity to diabetes.” Nature, Vol. 409, No. 6818, 2001,
pp. 307-12.
[17] Lazar, M.A. “Resistin-and obesity-associated metabolic diseases.” Hormone and Metabolic Research, Vol. 39,
No. 10, 2007, pp. 710-16.
[18] Iglesias, Pedro, et al. “Serum concentrations of adipocytokines in patients with hyperthyroidism and
hypothyroidism before and after control of thyroid function.” Clinical Endocrinology, Vol. 59, No. 5, 2003, pp.
621-29.
[19] Yaturu, Subhashini, Susan Prado, and Sidney R. Grimes. “Changes in adipocyte hormones leptin, resistin, and
adiponectin in thyroid dysfunction.” Journal of Cellular Biochemistry, Vol. 93, No. 3, 2004, pp. 491-96.
[20] Krassas, Gerasimos E., et al. “Resistin levels in hyperthyroid patients before and after restoration of thyroid
function: relationship with body weight and body composition.” European Journal of Endocrinology, Vol. 153,
No. 2, 2005, pp. 217-21.
[21] Bossowski, Artur, et al. “Analysis of serum adiponectin, resistin and leptin levels in children and adolescents
with autoimmune thyroid disorders.” Journal of Pediatric Endocrinology and Metabolism, Vol. 23, No. 4, 2010,
pp. 369-77.
[22] Hedayati, Mehdi, et al. “Serum level of resistin in patients with hyperthyroidism and hypothyroidism.” Zahedan
Journal of Research in Medical Sciences, Vol. 16, No. 11, 2013.
[23] SAS Institute Inc.: SAS 9.1 (9.1 TS1M0) [software]. 2012 [cited 2017 Sep 14]. Available from: http://support.
sas.com/documentation/onlinedoc/91pdf/index.html.
[24] Chen, Yanyan, et al. “Changes in profile of lipids and adipokines in patients with newly diagnosed hypothyroidism
and hyperthyroidism.” Scientific Reports, Vol. 6, 2016.
[25] Ibrahim, Maher K. “Association between leptin hormone and thyroid hormone levels in hypothyroid, hyperthyroid
and euthyroid subjects.” Frontiers in Biomedical Sciences, Vol. 1, No. 2, pp. 39-44.
[26] Nakamura, Tomoatsu, et al. “Association of hyperthyroidism with serum leptin levels.” Metabolism, Vol. 49,
No. 10, 2000, pp. 1285-88.
[27] Diekman, M.J.M., et al. “Thyroid hormones modulate serum leptin levels: observations in thyrotoxic and
hypothyroid women.” Thyroid, Vol. 8, No. 12, 1998, pp. 1081-86.
Al-Hindawi Sahar H Int J Med Res Health Sci 2018, 7(1): 40-47
47
[28] Medina-Gomez, Gema, Rosa-Maria Calvo, and Maria-Jesus Obregón. “T3 and Triac inhibit leptin secretion
and expression in brown and white rat adipocytes.” Biochimica et Biophysica Acta (BBA)-Molecular and Cell
Biology of Lipids, Vol. 1682, No. 1, 2004, pp. 38-47.
[29] Ortiga-Carvalho, T.M., et al. “The role of leptin in the regulation of TSH secretion in the fed state: In vivo and
in vitro studies.” Journal of Endocrinology, Vol. 174, No. 1, 2002, pp. 121-25.
[30] Rosenbaum, Michael, et al. “Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine
adaptations to maintenance of reduced weight.” Journal of Clinical Investigation, Vol. 115, No. 12, 2005, p.
3579.
[31] Araujo, Renata L., and Denise P. Carvalho. “Bioenergetic impact of tissue-specific regulation of iodothyronine
deiodinases during nutritional imbalance.” Journal of Bioenergetics and Biomembranes, Vol. 43, No. 1, 2011,
pp. 59-65.
[32] Eke Koyuncu, Ceren, et al. “Serum resistin and insulin-like growth factor-1 levels in patients with hypothyroidism
and hyperthyroidism.” Journal of Thyroid Research, Vol. 2013, 2013.
[33] Krassas, G.E., et al. “Resistin levels are normal in hypothyroidism and remain unchanged after attainment of
euthyroidism: Relationship with insulin levels and anthropometric parameters.” Journal of Endocrinological
Investigation, Vol. 29, No. 7, 2006, pp. 606-12.
[34] Roef, Greet, et al. “Body composition and metabolic parameters are associated with variation in thyroid hormone
levels among euthyroid young men.” European Journal of Endocrinology, Vol. 167, No. 5, 2012, pp. 719-26.

Thank you for copying data from http://www.arastirmax.com